Originally published at IHIF EMEA 2026
Every physical condition risk in a hotel asset – structural integrity, fire safety, HVAC performance, water quality – has standardised inspection, documentation, and a recognised impact on valuation. Every risk except one.
Bed bug exposure has historically sat in facilities budgets as an unpredictable operational cost: invisible in due diligence, unquantifiable in underwriting, absent from ESG reporting. That is changing. Regulatory, technological, and procurement forces are converging to close this gap – and the early-mover markets have already demonstrated how quickly it happens.
This article maps the shift across four dimensions – asset valuation, financial performance, brand reputation, and ESG compliance – and examines what the evidence from Paris and other adopting markets means for how hotel assets are valued, transacted, and differentiated.The shift: infestations have become structural, not temporary
Hotel investment professionals assess dozens of physical condition variables: HVAC remaining life, fire suppression compliance, Legionella management. Each has an accepted inspection standard, a documentation trail, and a quantifiable impact on transaction value. Pest condition has none.
The default approach is reactive: respond after detection, engage contractors, treat with chemical pesticides, log internally. No standardised protocol, no third-party certification, no data flowing into underwriting. This was tolerable when reactive treatment reliably resolved incidents. It does not.
Industry data paints a picture that should concern anyone conducting due diligence on a hotel asset. Hotels average 7.1 bed bug infestations every five years. Fifty percent of chemically treated infestations require retreatment within 12 months. Seventy percent require multiple treatment rounds to resolve.
This is not a problem that reactive treatment solves. It is a recurring condition of the asset class. The question for any transaction is not whether a given property has experienced infestations – statistically, it almost certainly has – but whether the current approach produces durable outcomes or a cycle of recurring cost and risk.
Martim Gois, Founder and CEO of Valpas, at the IHIF EMEA CEO Council, Berlin
The EU is tightening restrictions on neonicotinoid-based pesticides – the chemicals that underpin most reactive bed bug treatment. The European Commission's forthcoming EU Ecolabel revision for tourist accommodations will formally distinguish between reactive biocide treatments and verified prevention-based systems. As the chemicals become harder to use and the regulatory cost of using them rises, the reactive model is not just ineffective – it is becoming non-viable.
For a 200-room urban luxury hotel experiencing two incidents per year, the annualised P&L exposure exceeds €150K in direct costs – room displacement, treatment, compensation, operational disruption – before reputational damage. As treatment options narrow, this figure escalates rather than stabilises.
The implication for asset valuation is direct: an unpriced condition risk is becoming a priced one. The assets that have permanent safety infrastructure carry a quantifiably different risk profile from those that do not.How this sits on the balance sheet and P&L.
Permanent safety infrastructure changes where pest-related costs appear in the financial structure of a hotel asset. The distinction matters for how NOI is calculated, how the asset is valued, and how risk is modelled.
Under the reactive model, every infestation triggers costs that flow directly through the P&L as unpredictable operational expenditure:
Permanent safety infrastructure replaces this entire cost stack with a fixed annual commitment per room. The economics shift in three ways.
A decade ago, a bed bug incident was a private inconvenience. Today, a single incident generates a review that persists indefinitely across every platform surfacing guest feedback. The reputational half-life of a bed bug report has lengthened from weeks to years. Three forces are accelerating this.
Review platforms no longer decay old content. A bed bug mention from 2023 surfaces alongside last week's reviews in aggregated ratings, AI-generated summaries, and search results. The signal never clears.
AI booking agents and travel assistants are already making recommendations on behalf of corporate and leisure travellers, trained on structured, verifiable data. A hotel without verified permanent safety is a hotel these systems cannot confidently recommend. As AI intermediation grows, the absence of machine-readable safety certification becomes a structural disadvantage in rate and distribution – the same dynamic that made energy performance certificates table stakes for online distribution.
GBTA data from 2025 shows safety and duty-of-care concerns among corporate travel professionals reached 46%, rising nine percentage points year-on-year. Travel managers are formalising what preferred hotel programmes require. Verifiable permanent safety is entering RFP criteria. For asset managers, this is occupancy mix risk: exclusion from the corporate programmes that anchor weekday demand and underpin rate assumptions.
A single unmanaged incident depresses demand across channels for an extended period, affecting both the rooms directly impacted and the property's positioning.
Martim Gois, Founder and CEO of Valpas, at the EEA Roundtable, IHIF EMEA, Berlin
Hotels are among the heaviest indoor users of neonicotinoid-based pesticides – the same class of chemicals linked to the collapse of pollinator populations globally. The World Sustainable Hospitality Alliance's 2025 report on detoxing hotel guest rooms documents the scale of this exposure.
For portfolios reporting against ESG frameworks – and for lenders and investors who weight ESG compliance in capital allocation – the gap between published sustainability commitments and actual chemical pesticide use is becoming auditable. Permanent safety closes it: zero pesticides, real-time verification, full framework alignment.
Marriott Champs-Élysées, Paris – one of over 100 Valpas-certified hotel assets in the city
Paris offers the clearest evidence of adoption velocity. Following the 2023 bed bug crisis that drew international coverage, the luxury market did not wait for regulation. It moved through three tiers in under eighteen months:
For professionals who evaluate, transact, and finance hotel assets, permanent safety is introducing a new variable across multiple dimensions of the deal.
For anyone currently in due diligence on a hotel acquisition or disposition, this creates concrete questions to ask – and concrete adjustments to make if the answers are unsatisfactory.
Valpas is real-time asset condition infrastructure for hotels – the same category as fire safety certification or water quality monitoring, applied to the one physical condition risk that has until now lacked a standard. Valpas certifies properties and pushes verified proof directly to OTAs, AI systems, valuators, and ESG certifiers. 30,000+ rooms across 80+ destinations with operators including Marriott and Aman, owners including Aroundtown and Covivio.
Sources and references
GBTA Business Travel Sentiment Poll, 2025. Orkin Hospitality Industry Report: Behind the Cost of Bed Bugs, 2024. WSHA, Detoxing Hotel Guest Rooms, 2025. UK hotel bed bug survey (2.5M stays), East London Advertiser / This Is Local London, 2024. Rentokil pest activity data, 2023–2024. ThermoPest London enquiry data, summer 2025. PwC UK Hotels Forecast 2025–2026. 2023 Paris bed bug crisis: BBC, NPR, Al Jazeera, CBS News. GSTC, Travalyst, WSHA framework references. European Commission EU Ecolabel revision (forthcoming). Valpas operational and market data, 2024–2025.
